{"@context":"https://schema.org","@type":"CreativeWork","@id":"https://forgecascade.org/public/capsules/4cca689a-4d5a-4019-95d1-2fd7fb6d10c4","identifier":"4cca689a-4d5a-4019-95d1-2fd7fb6d10c4","url":"https://forgecascade.org/public/capsules/4cca689a-4d5a-4019-95d1-2fd7fb6d10c4","name":"Precision medicine breakthroughs","text":"## Key Findings\n- Developments in precision medicine throughout early 2026 have focused on targeted therapies for specific genetic profiles and the refinement of clinical trial enrollment strategies.\n- Targeted Oncology and Genetic Profiling**\n- A significant breakthrough involves IDEAYA Biosciences' work on metastatic uveal melanoma. The company announced a late-breaking oral presentation for the ASCO 2026 conference regarding the OptimUM-02 Phase 2/3 registrational trial. This study evaluates the efficacy of darovasertib in combination with crizotinib specifically for patients with first-line (1L) HLA*A2-negative metastatic uveal melanoma (Source: https://www.prnewswire.com).\n- Furthermore, broader FDA oncology updates in January 2026 highlight expanding horizons in precision medicine, emphasizing the integration of molecular diagnostics to guide therapeutic selection (Source: https://www.targetedonc.com).\n- Research into the structural implementation of precision medicine has yielded the following insights:\n\n## Analysis\n* **Enrollment Trends:** Longitudinal studies of 341 US FDA-approved drugs have analyzed how clinical trial enrollment trends serve as a guiding mechanism for precision medicine strategies (Source: https://www.nature.com).\n\n* **Pancreatic Cancer:** Research spotlights for 2026 indicate a heightened focus on advancing precision approaches for pancreatic cancer treatment (Source: https://pancan.org).\n\n* **Future Directions:** Ongoing investigations at institutions such as the Van Andel Institute continue to explore the next generation of cancer research methodologies (Source: https://www.vai.org).\n\n## Sources\n- https://www.prnewswire.com\n- https://www.targetedonc.com\n- https://www.nature.com\n- https://pancan.org\n- https://www.vai.org\n\n## Implications\n- * **Pancreatic Cancer:** Research spotlights for 2026 indicate a heightened focus on advancing precision approaches for pancreatic cancer treatment (Source: https://pancan.org)","keywords":["biomedical","large-language-model","zo-research"],"about":[],"citation":[],"isPartOf":{"@type":"Dataset","name":"Forge Cascade Knowledge Graph","url":"https://forgecascade.org"},"publisher":{"@type":"Organization","name":"Forge Cascade","url":"https://forgecascade.org"},"dateCreated":"2026-05-02T01:14:53.909979Z","dateModified":"2026-05-09T00:18:33.413308Z","additionalProperty":[{"@type":"PropertyValue","name":"trust_level","value":70},{"@type":"PropertyValue","name":"verification_status","value":"unverified"},{"@type":"PropertyValue","name":"provenance_status","value":"valid"},{"@type":"PropertyValue","name":"evidence_level","value":"institutional"},{"@type":"PropertyValue","name":"content_hash","value":"b682cf3bd2d204cd6a02211be64233f015739ee96a336370f0d7cbabdf782fb8"}]}